ADAMTS Proteases: Their Multifaceted Role in the Regulation of Cancer Metastasis

Overview

Journal Dis Res

Date 2024 Jul 1

PMID 38948119

Authors

Rachele Bacchetti

Shengnan Yuan

Elena Rainero

Affiliations

Soon will be listed here.

Abstract

Cancer leads to nearly 10 million deaths worldwide per year. The tumour microenvironment (TME) is fundamental for tumour growth and progression. A key component of the TME, the extracellular matrix (ECM) has recently become a focus of interest in cancer research. Dysregulation of ECM synthesis and proteolysis leads to uncontrolled tumour growth and metastasis. Matrix remodelling enzymes, secreted by cancer cells and stromal cells, modify the overall structure and organisation of ECM proteins, therefore influencing biochemical interactions, tissue integrity and tissue turnover. While A Disintegrin and Metalloproteinases (ADAMs)' and matrix metalloproteinases' role in cancer has been deeply investigated, other proteolytic enzymes, like ADAMs with thrombospondin(-like) motifs (ADAMTSs) have been gaining interest due to their roles in modulating cancer cell-ECM interactions and oncogenic signalling pathways. In this review, we will discuss the dysregulation of ADAMTSs in cancer and their roles in regulating cancer development and progression, via ECM remodelling and cell signalling modulation.

References

Haraguchi N, Ohara N, Koseki J, Takahashi H, Nishimura J, Hata T . High expression of ADAMTS5 is a potent marker for lymphatic invasion and lymph node metastasis in colorectal cancer. Mol Clin Oncol. 2017; 6(1):130-134. PMC: 5244970. DOI: 10.3892/mco.2016.1088. View

Stanton H, Melrose J, Little C, Fosang A . Proteoglycan degradation by the ADAMTS family of proteinases. Biochim Biophys Acta. 2011; 1812(12):1616-29. DOI: 10.1016/j.bbadis.2011.08.009. View

Yip H, Papa A . Signaling Pathways in Cancer: Therapeutic Targets, Combinatorial Treatments, and New Developments. Cells. 2021; 10(3). PMC: 8002322. DOI: 10.3390/cells10030659. View

Shindo T, Kurihara H, Kuno K, Yokoyama H, Wada T, Kurihara Y . ADAMTS-1: a metalloproteinase-disintegrin essential for normal growth, fertility, and organ morphology and function. J Clin Invest. 2000; 105(10):1345-52. PMC: 315464. DOI: 10.1172/JCI8635. View

Cross N, Chandrasekharan S, Jokonya N, Fowles A, Hamdy F, Buttle D . The expression and regulation of ADAMTS-1, -4, -5, -9, and -15, and TIMP-3 by TGFbeta1 in prostate cells: relevance to the accumulation of versican. Prostate. 2004; 63(3):269-75. DOI: 10.1002/pros.20182. View

Nandadasa S, Nelson C, Apte S . ADAMTS9-Mediated Extracellular Matrix Dynamics Regulates Umbilical Cord Vascular Smooth Muscle Differentiation and Rotation. Cell Rep. 2015; 11(10):1519-28. PMC: 4472575. DOI: 10.1016/j.celrep.2015.05.005. View

Song C, Chen J, Zhang C, Dong D . An Integrated Pan-Cancer Analysis of ADAMTS12 and Its Potential Implications in Pancreatic Adenocarcinoma. Front Oncol. 2022; 12:849717. PMC: 8904364. DOI: 10.3389/fonc.2022.849717. View

Sun W, Ma G, Zhang L, Wang P, Zhang N, Wu Z . DNMT3A-mediated silence in ADAMTS9 expression is restored by RNF180 to inhibit viability and motility in gastric cancer cells. Cell Death Dis. 2021; 12(5):428. PMC: 8087691. DOI: 10.1038/s41419-021-03628-5. View

de Assis Lima M, Vieira Da Silva S, Serrano-Garrido O, Hulsemann M, Santos-Neres L, Rodriguez-Manzaneque J . Metalloprotease ADAMTS-1 decreases cell migration and invasion modulating the spatiotemporal dynamics of Cdc42 activity. Cell Signal. 2020; 77:109827. PMC: 7723338. DOI: 10.1016/j.cellsig.2020.109827. View

10.

Jiang Y, Yu X, Zhao Y, Huang J, Li T, Chen H . ADAMTS19 Suppresses Cell Migration and Invasion by Targeting S100A16 via the NF-κB Pathway in Human Gastric Cancer. Biomolecules. 2021; 11(4). PMC: 8070242. DOI: 10.3390/biom11040561. View

11.

Ataca D, Aouad P, Constantin C, Laszlo C, Beleut M, Shamseddin M . The secreted protease Adamts18 links hormone action to activation of the mammary stem cell niche. Nat Commun. 2020; 11(1):1571. PMC: 7099066. DOI: 10.1038/s41467-020-15357-y. View

12.

Moncada-Pazos A, Obaya A, Fraga M, Viloria C, Capella G, Gausachs M . The ADAMTS12 metalloprotease gene is epigenetically silenced in tumor cells and transcriptionally activated in the stroma during progression of colon cancer. J Cell Sci. 2009; 122(Pt 16):2906-13. DOI: 10.1242/jcs.050468. View

13.

Shen Q, Polom K, Williams C, Marques Souza de Oliveira F, Guergova-Kuras M, Lisacek F . A targeted proteomics approach reveals a serum protein signature as diagnostic biomarker for resectable gastric cancer. EBioMedicine. 2019; 44:322-333. PMC: 6606959. DOI: 10.1016/j.ebiom.2019.05.044. View

14.

Dancevic C, Fraser F, Smith A, Stupka N, Ward A, McCulloch D . Biosynthesis and expression of a disintegrin-like and metalloproteinase domain with thrombospondin-1 repeats-15: a novel versican-cleaving proteoglycanase. J Biol Chem. 2013; 288(52):37267-76. PMC: 3873579. DOI: 10.1074/jbc.M112.418624. View

15.

Kordowski F, Kolarova J, Schafmayer C, Buch S, Goldmann T, Marwitz S . Aberrant DNA methylation of ADAMTS16 in colorectal and other epithelial cancers. BMC Cancer. 2018; 18(1):796. PMC: 6080380. DOI: 10.1186/s12885-018-4701-2. View

16.

Ren P, Hughes M, Krishnamoorthy S, Zou S, Zhang L, Wu D . Critical Role of ADAMTS-4 in the Development of Sporadic Aortic Aneurysm and Dissection in Mice. Sci Rep. 2017; 7(1):12351. PMC: 5617887. DOI: 10.1038/s41598-017-12248-z. View

17.

Yue B . Biology of the extracellular matrix: an overview. J Glaucoma. 2014; 23(8 Suppl 1):S20-3. PMC: 4185430. DOI: 10.1097/IJG.0000000000000108. View

18.

Niland S, Eble J . Hold on or Cut? Integrin- and MMP-Mediated Cell-Matrix Interactions in the Tumor Microenvironment. Int J Mol Sci. 2020; 22(1). PMC: 7794804. DOI: 10.3390/ijms22010238. View

19.

Zou R, Gu R, Tu X, Chen J, Liu S, Xue X . Effects of metalloprotease ADAMTS12 on cervical cancer cell phenotype and its potential mechanism. Discov Oncol. 2023; 14(1):162. PMC: 10465472. DOI: 10.1007/s12672-023-00776-2. View

20.

Nie J, Dang S, Zhu R, Lu T, Zhang W . ADAMTS18 deficiency associates extracellular matrix dysfunction with a higher risk of HER2-positive mammary tumorigenesis and metastasis. Breast Cancer Res. 2024; 26(1):19. PMC: 10826190. DOI: 10.1186/s13058-024-01771-3. View